1. Home
  2. EHTH vs ELUT Comparison

EHTH vs ELUT Comparison

Compare EHTH & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

N/A

Current Price

$1.20

Market Cap

46.0M

Sector

Finance

ML Signal

N/A

Logo Elutia Inc.

ELUT

Elutia Inc.

N/A

Current Price

$0.88

Market Cap

42.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EHTH
ELUT
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.0M
42.5M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
EHTH
ELUT
Price
$1.20
$0.88
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$3.33
$6.00
AVG Volume (30 Days)
228.5K
56.0K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
146.77
EPS
N/A
N/A
Revenue
$251,395,000.00
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
$10.83
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.14
$0.50
52 Week High
$5.89
$2.38

Technical Indicators

Market Signals
Indicator
EHTH
ELUT
Relative Strength Index (RSI) 37.55 49.02
Support Level N/A $0.84
Resistance Level $1.58 $1.04
Average True Range (ATR) 0.05 0.08
MACD 0.00 0.01
Stochastic Oscillator 21.43 51.53

Price Performance

Historical Comparison
EHTH
ELUT

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: